Quest Diagnostics Inc's Suppliers recorded an increase in sales by 8.18 % year on year in Q2 2026, sequentially sales grew by 7.96 %, Quest Diagnostics Inc recorded an increase in cost of sales by 10.89 % year on year, sequentially cost of sales grew by 3.23 % in Q2.
Quest Diagnostics Inc's Suppliers recorded an increase in sales by 8.18 % year on year in Q2 2026, sequentially sales grew by 7.96 %, Quest Diagnostics Inc recorded increase in cost of sales by 10.89 % year on year, sequentially cost of sales grew by 3.23 % in Q2.
The company maintains a Supplier Quality Program to ensure a high-quality supplier network and elevate quality standards. It emphasizes operational efficiency through standardization, optimization, digitization, and automation throughout its value chain. The cost excellence program, Invigorate, targets savings and productivity improvements in patient services, logistics, laboratory operations, revenue services, IT, and procurement. Automation and artificial intelligence are applied to enhance quality and productivity, including specimen processing and labeling in multiple laboratories. The company launched Project Nova to modernize Order to Cash business processes, collaborating with Epic, a third-party licensor, for implementation. This initiative seeks to streamline operations, reduce technology costs, accelerate revenue, and improve customer and patient experience. The business is organized by clinical franchises to concentrate on growth and customer solutions.
Quest Diagnostics Inc's Comment on Supply Chain
The company maintains a Supplier Quality Program to ensure a high-quality supplier network and elevate quality standards. It emphasizes operational efficiency through standardization, optimization, digitization, and automation throughout its value chain. The cost excellence program, Invigorate, targets savings and productivity improvements in patient services, logistics, laboratory operations, revenue services, IT, and procurement. Automation and artificial intelligence are applied to enhance quality and productivity, including specimen processing and labeling in multiple laboratories. The company launched Project Nova to modernize Order to Cash business processes, collaborating with Epic, a third-party licensor, for implementation. This initiative seeks to streamline operations, reduce technology costs, accelerate revenue, and improve customer and patient experience. The business is organized by clinical franchises to concentrate on growth and customer solutions.
DGX's Suppliers Net Income grew by
DGX's Suppliers Net margin grew in Q2 to
14.83 %
7.77 %
DGX's Suppliers Net Income grew by 14.83 %
DGX's Suppliers Net margin grew in Q2 to 7.77 %
Quest Diagnostics Inc's Suppliers Sales Growth
in Q2 2026 by Industry
Sources:
Quest Diagnostics Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Quest Diagnostics Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
31.08 %